Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Kitani

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|October 22, 2005
Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotidesStefan Fichtner-Feigl, Ivan J Fuss, Jan C Preiss, et al.
Gut Microbes|June 4, 2011
Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infectionTomohiro Watanabe, Naoki Asano, Atsushi Kitani, et al.
Immunity|September 5, 2006
Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitisTomohiro Watanabe, Atsushi Kitani, Peter J Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and miceKazuhiko Nakamura, Atsushi Kitani, Ivan Fuss, et al.
Gastroenterology|October 22, 2008
IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitisStefan Fichtner-Feigl, Cheryl A Young, Atsushi Kitani, et al.
The Journal of Clinical Investigation|January 3, 2020
Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitisLiming Mao, Atsushi Kitani, Eitaro Hiejima, et al.
The Journal of Clinical Investigation|January 12, 2008
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitisTomohiro Watanabe, Naoki Asano, Peter J Murray, et al.
Science Translational Medicine|June 8, 2018
An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitisTetsuya Takagawa, Atsushi Kitani, Ivan Fuss, et al.
Frontiers in Immunology|October 3, 2022
Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory functionLiming Mao, Atika Dhar, Guangxun Meng, et al.
Gastroenterology|October 5, 2007
NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis inductionZhiqiong Yang, Ivan J Fuss, Tomohiro Watanabe, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|October 22, 2005
Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotidesStefan Fichtner-Feigl, Ivan J Fuss, Jan C Preiss, et al.
Gut Microbes|June 4, 2011
Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infectionTomohiro Watanabe, Naoki Asano, Atsushi Kitani, et al.
Immunity|September 5, 2006
Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitisTomohiro Watanabe, Atsushi Kitani, Peter J Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and miceKazuhiko Nakamura, Atsushi Kitani, Ivan Fuss, et al.
Gastroenterology|October 22, 2008
IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitisStefan Fichtner-Feigl, Cheryl A Young, Atsushi Kitani, et al.
The Journal of Clinical Investigation|January 3, 2020
Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitisLiming Mao, Atsushi Kitani, Eitaro Hiejima, et al.
The Journal of Clinical Investigation|January 12, 2008
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitisTomohiro Watanabe, Naoki Asano, Peter J Murray, et al.
Science Translational Medicine|June 8, 2018
An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitisTetsuya Takagawa, Atsushi Kitani, Ivan Fuss, et al.
Frontiers in Immunology|October 3, 2022
Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory functionLiming Mao, Atika Dhar, Guangxun Meng, et al.
Gastroenterology|October 5, 2007
NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis inductionZhiqiong Yang, Ivan J Fuss, Tomohiro Watanabe, et al.
Pageof 5